{"id":"https://openalex.org/W3168653701","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","title":"IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome.","display_name":"IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome.","publication_year":2021,"publication_date":"2021-05-20","ids":{"openalex":"https://openalex.org/W3168653701","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","mag":"3168653701"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.15_suppl.7566","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033769552","display_name":"Caspian H. Oliai","orcid":"https://orcid.org/0000-0002-6368-8557","observed_orcids":["https://orcid.org/0000-0002-6368-8557"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caspian Oliai","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044240892","display_name":"Anna Crosetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Crosetti","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081213752","display_name":"Sven de Vos","orcid":"https://orcid.org/0000-0002-6715-4851","observed_orcids":["https://orcid.org/0000-0002-6715-4851"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sven De Vos","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070465562","display_name":"Herbert Aaron Eradat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert Eradat","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078705613","display_name":"Monica Diane Mead","orcid":"https://orcid.org/0000-0001-9175-0189","observed_orcids":["https://orcid.org/0000-0001-9175-0189"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Diane Mead","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Marie Larson","raw_affiliation_strings":["Univ of California Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of California Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101921582","display_name":"Steven C. Tsai","orcid":"https://orcid.org/0009-0007-6329-7787","observed_orcids":["https://orcid.org/0009-0007-6329-7787"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Tsai","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090492571","display_name":"Annabel Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annabel Liu","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034980363","display_name":"Gina Khachatrian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina Khachatrian","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032419369","display_name":"Christopher A. Hannigan","orcid":"https://orcid.org/0000-0002-3506-1271","observed_orcids":["https://orcid.org/0000-0002-3506-1271"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Hannigan","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018823792","display_name":"Reiko E. Yamada","orcid":"https://orcid.org/0000-0002-2680-6972","observed_orcids":["https://orcid.org/0000-0002-2680-6972"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reiko E. Yamada","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024990832","display_name":"Neiki Rokni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neiki Rokni","raw_affiliation_strings":["UCLA Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Timmerman","raw_affiliation_strings":["University of California, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"15_suppl","first_page":"7566","last_page":"7566"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.8930000066757202},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.8889999985694885},{"id":"https://openalex.org/keywords/anakinra","display_name":"anakinra","score":0.9769999980926514},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9210000038146973},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9549999833106995},{"id":"https://openalex.org/keywords/large-b-cell-lymphoma","display_name":"large B-cell lymphoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/neurotoxicity-prevention","display_name":"neurotoxicity prevention","score":0.7860000133514404},{"id":"https://openalex.org/keywords/il-1-inhibition","display_name":"IL-1 inhibition","score":0.6269999742507935},{"id":"https://openalex.org/keywords/timing-of-prophylaxis","display_name":"timing of prophylaxis","score":0.6209999918937683},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.6320000290870667},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.6850000023841858},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8394416570663452},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.7913494110107422},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4435276985168457},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.06919923424720764}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.15_suppl.7566","doi":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.7566","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389247606","https://openalex.org/W3214715829","https://openalex.org/W4389231008","https://openalex.org/W4206626897","https://openalex.org/W4382632496","https://openalex.org/W4281767517","https://openalex.org/W4417010313","https://openalex.org/W4362693419","https://openalex.org/W3211869162","https://openalex.org/W4391602541"],"abstract_inverted_index":{"7566":[0],"Background:":[1],"Progress":[2],"in":[3,13,27,32,76,156,204,325,329],"chimeric":[4],"antigen":[5],"receptor":[6,70],"(CAR)":[7],"T-cell":[8,356],"therapy":[9],"has":[10],"included":[11,111],"reduction":[12],"life-threatening":[14],"toxicity.":[15],"Rates":[16],"of":[17,40,59,66,89,124,159,202,261,370],"severe":[18,41,104,206,238,257,305,335,344],"cytokine":[19],"release":[20],"syndrome":[21],"(CRS)":[22],"have":[23,221],"declined":[24],"from":[25],"50%":[26],"early":[28,87,338],"trials":[29],"to":[30,102,140,145,177,183,198,211,228,237,256,292,315,323,342,349,353,359,365,374],"7%":[31],"the":[33,90,157,166,173,200,233,249,288,312,326,366],"most":[34,269],"recent":[35],"real-world":[36],"experience.":[37],"However,":[38],"rates":[39],"immune":[42],"effector":[43],"cell-associated":[44],"neurotoxicity":[45,75],"(ICANS)":[46],"associated":[47,346],"with":[48,347],"axicabtagene":[49],"ciloleucel":[50],"(Axicel)":[51],"remain":[52],"unchanged.":[53],"IL-1":[54,69,379],"is":[55,63,197,321,372,381],"a":[56,96,350],"major":[57],"driver":[58],"ICANS":[60,105,138,151,207,345],"pathophysiology":[61],"that":[62],"produced":[64],"upstream":[65],"IL-6.":[67],"The":[68,143,194,268],"antagonist,":[71],"Anakinra,":[72,184],"can":[73],"prevent":[74,103],"animal":[77],"models":[78],"when":[79],"given":[80],"at":[81,279,331],"fever":[82],"onset.":[83],"We":[84],"present":[85],"our":[86],"experience":[88],"first":[91,167,234],"13":[92,219],"participants":[93,169,186,220,251],"enrolled":[94],"into":[95],"phase":[97],"II":[98],"trial":[99,110,385],"evaluating":[100],"Anakinra":[101,129,147,176,203,230,254,294,320],"(NCT4205838).":[106],"Methods:":[107],"This":[108],"investigator-sponsored":[109],"adults":[112],"eligible":[113],"for":[114,117,175,190,295,334],"standard-of-care":[115,188],"Axicel":[116,348],"large":[118],"B-cell":[119],"lymphoma":[120],"after":[121,165],"\u22652":[122,179,297],"lines":[123],"intensive":[125],"chemoimmunotherapy.":[126],"Participants":[127],"received":[128,187,232,253],"100":[130],"mg":[131],"SQ":[132],"q6h":[133],"x":[134],"12-36":[135],"doses":[136],"until":[137],"returned":[139],"grade":[141,150,153,178,265,280,296],"\u22641.":[142],"trigger":[144,174],"initiate":[146,229,293,324],"was":[148,242,273,290],"any":[149],"or":[152],"\u22653":[154],"CRS":[155,191,298],"absence":[158],"ICANS.":[160,193,239,267,336],"A":[161],"protocol":[162,289],"modification,":[163],"made":[164],"3":[168,266],"were":[170,283],"treated,":[171],"changed":[172],"CRS.":[180],"In":[181],"addition":[182],"all":[185],"interventions":[189],"and":[192,224,231,307,358],"primary":[195],"objective":[196],"estimate":[199],"efficacy":[201],"preventing":[205],"(grade":[208],"\u22653)":[209],"according":[210],"ASTCT":[212],"2018":[213],"consensus":[214],"grading.":[215],"Results:":[216],"To":[217],"date,":[218],"been":[222],"enrolled,":[223],"7":[225,250,262],"met":[226,311],"criteria":[227],"dose":[235],"prior":[236,255],"Median":[240],"age":[241],"56":[243],"years":[244],"(range,":[245],"23-84":[246],"years).":[247],"Of":[248],"whom":[252],"ICANS,":[258,306],"only":[259,308],"1":[260],"(14%)":[263],"developed":[264,304],"common":[270],"adverse":[271],"event":[272],"injection":[274],"site":[275],"reaction,":[276],"which":[277],"peaked":[278],"2.":[281],"There":[282],"no":[284,302],"unexpected":[285],"toxicities.":[286],"Once":[287],"amended":[291],"(N":[299],"=":[300],"4),":[301],"participant":[303,310],"one":[309],"institutional":[313],"standard":[314],"receive":[316],"corticosteroids":[317],"(Table).":[318],"Conclusions:":[319],"feasible":[322],"non-prophylactic":[327],"setting":[328],"patients":[330],"increased":[332],"risk":[333],"These":[337],"results":[339],"demonstrate":[340,375],"potential":[341],"reduce":[343,360],"rate":[351],"similar":[352],"other":[354],"CAR":[355],"products,":[357],"corticosteroid":[361],"use.":[362],"Further":[363],"enrollment":[364],"pre-planned":[367],"sample":[368],"size":[369],"N=36":[371],"required":[373],"statistical":[376],"efficacy.":[377],"Serum":[378],"analysis":[380],"also":[382],"ongoing.":[383],"Clinical":[384],"information:":[386],"NCT4205838.":[387],"[Table:":[388],"see":[389],"text]":[390]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-06-22T00:00:00"}